Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Farrell

Showing results (71-80 of 172) with videos related to

Pageof 18
Sort By:
International Journal of Antimicrobial Agents|May 27, 2014
Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012)David J Farrell, Helio S Sader, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease|October 20, 2010
Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: report from the SENTRY Antimicrobial Surveillance Program (1998-2009)Ronald N Jones, Helio S Sader, Gary J Moet, et al.
Diagnostic Microbiology and Infectious Disease|August 17, 2014
Ceftazidime-avibactam and comparator agents tested against urinary tract isolates from a global surveillance program (2011)Robert K Flamm, Helio S Sader, David J Farrell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2012
Oritavancin microbiologic features and activity results from the surveillance program in the United StatesRodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2016
Results from the Solithromycin International Surveillance Program (2014)David J Farrell, Robert K Flamm, Helio S Sader, et al.
International Journal of Antimicrobial Agents|March 8, 2013
Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010)David J Farrell, Robert K Flamm, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|October 9, 2013
Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa with various resistance patterns isolated in U.S. Hospitals (2011-2012)David J Farrell, Robert K Flamm, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2016
In Vitro Activity of Delafloxacin Tested against Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalisRobert K Flamm, Paul R Rhomberg, Michael D Huband, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2007
The macrolide resistance genes erm(B) and mef(E) are carried by Tn2010 in dual-gene Streptococcus pneumoniae isolates belonging to clonal complex CC271Maria Del Grosso, John G E Northwood, David J Farrell, et al.
The Journal of Antimicrobial Chemotherapy|April 13, 2011
Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance studyRonald N Jones, David J Farrell, Rodrigo E Mendes, et al.
Pageof 18

Showing results (71-80 of 172) with videos related to

Sort By:
Pageof 18
International Journal of Antimicrobial Agents|May 27, 2014
Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012)David J Farrell, Helio S Sader, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease|October 20, 2010
Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: report from the SENTRY Antimicrobial Surveillance Program (1998-2009)Ronald N Jones, Helio S Sader, Gary J Moet, et al.
Diagnostic Microbiology and Infectious Disease|August 17, 2014
Ceftazidime-avibactam and comparator agents tested against urinary tract isolates from a global surveillance program (2011)Robert K Flamm, Helio S Sader, David J Farrell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2012
Oritavancin microbiologic features and activity results from the surveillance program in the United StatesRodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2016
Results from the Solithromycin International Surveillance Program (2014)David J Farrell, Robert K Flamm, Helio S Sader, et al.
International Journal of Antimicrobial Agents|March 8, 2013
Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010)David J Farrell, Robert K Flamm, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|October 9, 2013
Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa with various resistance patterns isolated in U.S. Hospitals (2011-2012)David J Farrell, Robert K Flamm, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2016
In Vitro Activity of Delafloxacin Tested against Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalisRobert K Flamm, Paul R Rhomberg, Michael D Huband, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2007
The macrolide resistance genes erm(B) and mef(E) are carried by Tn2010 in dual-gene Streptococcus pneumoniae isolates belonging to clonal complex CC271Maria Del Grosso, John G E Northwood, David J Farrell, et al.
The Journal of Antimicrobial Chemotherapy|April 13, 2011
Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance studyRonald N Jones, David J Farrell, Rodrigo E Mendes, et al.
Pageof 18